138 related articles for article (PubMed ID: 26324021)
1. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells.
Jiang N; Chen W; Zhang JW; Li Y; Zeng XC; Zhang T; Fu BS; Yi HM; Zhang Q
Mol Med Rep; 2015 Nov; 12(5):7239-46. PubMed ID: 26458963
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
[No Abstract] [Full Text] [Related]
4. Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.
Yang B; Ma YF; Liu Y
Drug Res (Stuttg); 2015 Oct; 65(10):526-31. PubMed ID: 25368906
[TBL] [Abstract][Full Text] [Related]
5. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
6. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
Xie ZY; Lv K; Xiong Y; Guo WH
Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
Yakisich JS; Venkatadri R; Azad N; Iyer AKV
J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
[TBL] [Abstract][Full Text] [Related]
8. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
[TBL] [Abstract][Full Text] [Related]
9. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
[TBL] [Abstract][Full Text] [Related]
10. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
11. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
12. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
Xu R; Chen L; Yang WT
Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
[TBL] [Abstract][Full Text] [Related]
15. Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.
Ryoo IG; Lee SH; Kwak MK
Oxid Med Cell Longev; 2016; 2016():2428153. PubMed ID: 26682001
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
[TBL] [Abstract][Full Text] [Related]
18. Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.
Ishikawa T; Kajimoto Y; Sun W; Nakagawa H; Inoue Y; Ikegami Y; Miyatake S; Kuroiwa T
J Pharm Sci; 2013 Sep; 102(9):3058-69. PubMed ID: 23650051
[TBL] [Abstract][Full Text] [Related]
19. Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells.
Jia M; Wei Z; Liu P; Zhao X
J Korean Med Sci; 2016 Jun; 31(6):836-42. PubMed ID: 27247490
[TBL] [Abstract][Full Text] [Related]
20. Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
Chen HH; Chang HH; Chang JY; Tang YC; Cheng YC; Lin LM; Cheng SY; Huang CH; Sun MW; Chen CT; Kuo CC
Free Radic Biol Med; 2017 Dec; 113():505-518. PubMed ID: 29080842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]